We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc

Delisted

ARNA was delisted on the 10th of March, 2022.

1 hedge funds and large institutions have $0 invested in Arena Pharmaceuticals Inc in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 312 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 3161 (-315)

100% less funds holding in top 10

Funds holding in top 10: 70 (-7)

100% less capital invested

Capital invested by funds: $4.86B → $0 (-$4.86B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 312

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-315
Holders Change %
-99.68%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
1
Closed
312
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VIA
101
Vident Investment Advisory
Georgia
-$6.96M -74,881 Closed
LP
102
LMR Partners
United Kingdom
-$6.69M -71,984 Closed
Schroder Investment Management Group
103
Schroder Investment Management Group
United Kingdom
-$6.59M -70,916 Closed
PPA
104
Parametric Portfolio Associates
Washington
-$6.38M -68,598 Closed
TRSOTSOK
105
Teachers Retirement System of the State of Kentucky
Kentucky
-$6.1M -65,670 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
106
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$5.93M -63,800 Closed
SSA
107
Schonfeld Strategic Advisors
New York
-$5.91M -63,537 Closed
Voloridge Investment Management
108
Voloridge Investment Management
Florida
-$5.75M -61,909 Closed
New York State Common Retirement Fund
109
New York State Common Retirement Fund
New York
-$5.61M -60,353 Closed
Canada Pension Plan Investment Board
110
Canada Pension Plan Investment Board
Ontario, Canada
-$5.6M -60,300 Closed
IEFM
111
IQ EQ Fund Management
Ireland
-$5.54M -59,663 Closed
Nomura Holdings
112
Nomura Holdings
Japan
-$5.26M -56,564 Closed
CU
113
CQS (US)
New York
-$5.23M -56,250 Closed
PAMS
114
Pictet Asset Management (Switzerland)
Switzerland
-$5.22M -56,209 Closed
KCM
115
Kingdon Capital Management
New York
-$5.16M -55,555 Closed
AIMCA
116
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$5.06M -54,400 Closed
SFI
117
Susquehanna Fundamental Investments
Pennsylvania
-$5.03M -54,093 Closed
Legal & General Group
118
Legal & General Group
United Kingdom
-$4.7M -50,564 Closed
MOACM
119
Mutual of America Capital Management
New York
-$4.66M -50,146 Closed
Two Sigma Investments
120
Two Sigma Investments
New York
-$4.66M -50,095 Closed
AGM
121
Alpine Global Management
New York
-$4.63M -49,847 Closed
GC
122
Guggenheim Capital
Illinois
-$4.57M -49,194 Closed
State of New Jersey Common Pension Fund D
123
State of New Jersey Common Pension Fund D
New Jersey
-$4.4M -47,315 Closed
SM
124
SG3 Management
Puerto Rico
-$4.38M -47,100 Closed
PM
125
Prosight Management
Texas
-$4.18M -45,000 Closed

ARNA Hedge Fund Activity: Q1 2022 in Review

1 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2022, worth a combined $0 — down 100% from $4.86B a quarter earlier.

Sellers outnumbered buyers: 312 funds closed out of ARNA and 0 opened new positions — a net loss of 312 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $530M sold.

  • 1 institutional investor held Arena Pharmaceuticals Inc (ARNA) as of Q1 2022, down from 316 in Q4 2021.
  • Funds reported $0 of Arena Pharmaceuticals Inc stock for Q1 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Arena Pharmaceuticals Inc positions in Q1 2022 and 312 closed out, a net change of -312 holders.
  • The largest Arena Pharmaceuticals Inc seller in Q1 2022 was Vanguard Group, an estimated $530M sold.

Based on aggregated 13F filings for Q1 2022.